Search Within

Edmund King Bartlett

Formats
  1. Journal Article (35)
  2. Meeting Abstract (24)
  3. Review (6)
  4. Miscellaneous (5)
  5. Correspondence (4)
  6. Editorial (3)
  7. Guidelines (1)
Groups
  1. CTCR Scholars (78)
  2. MSK Grad Students (78)
  3. Master of Science in Clinical and Translational Cancer Research (78)
  4. Melanoma Disease Management Team (78)
  5. Surgery (78)
  6. Department of Medicine (41)

More Groups

People
  1. Charlotte Ariyan (25)
  2. Daniel Coit (23)
  3. Michael Marchetti (19)
  4. Danielle Bello (15)
  5. Mary Brady (14)
  6. Ciara Kelly (12)

More People

Years
  1. 2025 (6)
  2. 2024 (7)
  3. 2023 (20)
  4. 2022 (14)
  5. 2021 (9)
  6. 2020 (14)

More Years

Publications
  1. Annals of Surgical Oncology (27)
  2. Journal of the American College of Surgeons (8)
  3. JAMA Dermatology (5)
  4. Journal of Surgical Oncology (5)
  5. Journal of the American Academy of Dermatology (4)
  6. Annals of Oncology (3)

More Publications

Publishers
  1. Springer (27)
  2. Elsevier Science, Inc. (8)
  3. Wiley Blackwell (8)
  4. American Medical Association (7)
  5. American Society of Clinical Oncology (5)
  6. Oxford University Press (5)

More Publishers

Results (78)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic gene expression profiling in cutaneous melanoma: Identifying the knowledge gaps and assessing the clinical benefit
    Review

    Grossman, D.; Okwundu, N.; Bartlett, E. K.; Marchetti, M. A.; Othus, M.; Coit, D. G.; Hartman, R. I.; Leachman, S. A.; Berry, E. G.; Korde, L.; more...
    JAMA Dermatology (2020)

    Fulltext@MSK | Save
  • Performance of gene expression profile tests for prognosis in patients with localized cutaneous melanoma: A systematic review and meta-analysis
    Journal Article

    Marchetti, M. A.; Coit, D. G.; Dusza, S. W.; Yu, A.; McLean, L.; Hu, Y.; Nanda, J. K.; Matsoukas, K.; Mancebo, S. E.; Bartlett, E. K.
    JAMA Dermatology (2020)

    Fulltext@MSK | Save
  • Nodal and systemic recurrence following observation of a positive sentinel lymph node in melanoma
    Journal Article

    Bartlett, E. K.; Lee, A. Y.; Spanheimer, P. M.; Bello, D. M.; Brady, M. S.; Ariyan, C. E.; Coit, D. G.
    British Journal of Surgery (2020)

    Fulltext@MSK | Save
  • Timing is everything: Could surveillance imaging intensity influence survival in high-risk melanoma?
    Editorial

    Neuwirth, M. G.; Bartlett, E. K.
    Annals of Surgical Oncology (2020)

    Fulltext@MSK | Save
  • Interpretation of the complex melanoma pathology report
    Review

    Crompton, J. G.; Busam, K. J.; Bartlett, E. K.
    Surgical Oncology Clinics of North America (2020)

    Fulltext@MSK | Save
  • Disease presentation is highly prognostic in melanoma patients with occult nodal disease following sentinel lymph node biopsy
    Meeting Abstract

    Neuwirth, M.; Bello, D.; Brady, M. S.; Ariyan, C. E.; Coit, D. G.; Bartlett, E. K.
    Annals of Surgical Oncology (2020)

    Fulltext@MSK | Save
  • Response to checkpoint blockade and survival in patients with stage III melanoma
    Meeting Abstract

    Theriot, J.; Bello, D.; Lobaugh, S.; Bartlett, E. K.; Betof, A.; Shoushtari, A.; Postow, M.; Callahan, M.; Brady, M. S.; Wong, R.; more...
    Annals of Surgical Oncology (2020)

    Fulltext@MSK | Save
  • Outcomes in patients with stage IIC melanoma treated with excision alone
    Meeting Abstract

    Sharma, A.; Bello, D.; Ariyan, C. E.; Coit, D. G.; Brady, M. S.; Bartlett, E. K.
    Annals of Surgical Oncology (2020)

    Fulltext@MSK | Save
  • Objective response rate among patients with locally advanced or metastatic sarcoma treated with talimogene laherparepvec in combination with pembrolizumab: A phase 2 clinical trial
    Journal Article

    Kelly, C. M.; Antonescu, C. R.; Bowler, T.; Munhoz, R.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Dholakia, R.; more...
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • High neutrophil-to-lymphocyte ratio (NLR) is associated with treatment failure and death in patients who have melanoma treated with PD-1 inhibitor monotherapy
    Journal Article

    Bartlett, E. K.; Flynn, J. R.; Panageas, K. S.; Ferraro, R. A.; Sta.Cruz, J. M.; Postow, M. A.; Coit, D. G.; Ariyan, C. E.
    Cancer (2020)

    Fulltext@MSK | Save